The data existed
Liraglutide (a daily injection) produced a more modest average weight loss of about 4% to 5% , according to 24 trials (9,937 participants), but still increased the proportion of people who achieved clinically meaningful weight loss compared with placebo
Simultaneously, Akt phosphorylates the FOXO family of transcription factors (FOXO1, FOXO3, FOXO4), sequestering them in the cytoplasm and preventing them from transcribing the atrogenes MuRF1 and atrogin-1/MAFbx that drive ubiquitin-proteasome-mediated muscle protein breakdown
The timeline is longer than standard protocols, but the results are more sustainable
Wen B, Tang S, Lv X, Li D, Xu J, Olsen RKJ et al (2022) Clinical, pathological and genetic features and follow-up of 110 patients with late-onset MADD: a single-center retrospective study
Whats the Most Common Starting Protocol